Related by context. All words. (Click for frequent words.) 61 Nippon Shinyaku 60 ATL# [001] 60 PHX# 60 PSMA ADC 60 elotuzumab 60 Phase Ib II 60 ospemifene 60 Galenea 59 Loramyc ™ 59 VersaFilm 59 Telatinib 59 Targeted Chemotherapy 59 Fentanyl TAIFUN R 59 Phase Ib study 59 Potelligent Technology 59 mertansine 59 Phase lll 59 HalcyGen 59 Spiegelmer ® 59 Lupuzor 59 PDE4 inhibitor 59 BLA filing 58 ARIKACE ™ 58 eniluracil 58 AERx iDMS 58 Zensana TM 58 Oncolys 58 NADiA ProsVue 58 Argatroban 57 CytoFabTM 57 Aurora kinase inhibitor 57 outlicensed 57 VITAL Trial 57 Phase #b/#a clinical 57 TRX1 57 Vernalis plc 57 Rheoscience 57 BioGeneriX 57 EndoTAG TM 57 Taiho Pharmaceutical 57 WILEX 57 LCP AtorFen 57 pradefovir 57 PF # [002] 57 Zenyaku Kogyo 57 pivotal bioequivalence 57 Alnylam #x# 57 apaziquone 57 Evolva 57 outlicensing 57 nalbuphine ER 57 PLK1 SNALP 57 Lucanix R 57 Alnylam RNAi 57 Asubio 57 CIP TRAMADOL ER 57 Flutiform TM 57 HuCAL antibodies 56 NeuroSolutions 56 GLP toxicology studies 56 Pennsaid R 56 Sylvie Gregoire President 56 Sopherion 56 lixivaptan 56 Urocidin 56 Urocidin TM 56 AnGes 56 RIGScan CR 56 cathepsin K inhibitor 56 Sanochemia 56 Allovectin 7 56 IND submission 56 Bicifadine 56 initiated Phase Ib 56 JCR Pharmaceuticals 56 LGLS 56 Loramyc TM 56 Nippon Kayaku 56 deforolimus 56 Panzem R NCD 56 NASDAQ ALNY 56 AKT inhibitor 56 atacicept 55 TBC# 55 PEGylated interferon 55 HuMax TAC 55 aerosolized AAT 55 License Option Agreement 55 fipamezole 55 DeveloGen 55 Phase IIb clinical trials 55 Archexin 55 Phase IIb III 55 anti CD3 monoclonal 55 CVac 55 CIP ISOTRETINOIN 55 phase IIb trial 55 POTELLIGENT R Technology 55 therapeutic monoclonal antibody 55 Trastuzumab DM1 55 Alvesco R 55 inhaled formulation 55 Arqule 55 PREOS R 55 Paris IPN Euronext 55 OncoVEX 55 P#X# antagonist 55 Calixa Therapeutics 55 glucokinase activator 55 multi kinase inhibitor 55 PEP# [001] 55 initiate Phase 1b 55 BEMA TM Fentanyl 55 BIOCEUTICALS 55 Syntonix 55 dutogliptin 55 Toraymyxin TM 55 Nanobody R 55 CIMZIA ™ 55 Rapinyl 55 Phase #b/#a 55 phase IIb clinical 55 BrachySil TM 54 otelixizumab 54 Phase III HEAT 54 regorafenib 54 Phase Ib clinical 54 oral prodrug 54 Alnylam Nasdaq ALNY 54 oxymorphone ER 54 methylnaltrexone 54 elbion 54 HDL Selective Delipidation 54 TKM Ebola 54 Atugen 54 immunotherapeutic vaccine 54 Montigen 54 novel therapeutic antibodies 54 rALLy clinical trial 54 adrenergic regulation 54 ONCONASE R 54 CRMD# 54 Aplidin 54 antiinfective 54 Initiates Phase II 54 Kosan dependence 54 Zeneus 54 phase IIa clinical 54 Allovectin 7 r 54 Biovitrum AB 54 AcryMed Incorporated 54 oral PTH 54 EpiTherapeutics 54 Entocort 54 TOCOSOL Paclitaxel 54 Novosom 54 GlycArt 54 SinuNase ™ 54 ACAPODENE 54 SYN X 54 Phase 1b clinical 54 inhaled AAT 54 Angioblast 54 Fentanyl Taifun 54 CRD5 54 XOMA 3AB 54 KuDOS 54 JAK inhibitor 54 generation purine nucleoside 54 PrevOnco ™ 54 Cellgate 54 Cleviprex TM clevidipine 54 TKM ApoB 54 rPA vaccine candidate 54 Zebinix R 54 Hedgehog antagonist 54 DiaPep# 54 Handok Pharmaceuticals 54 MorphoSys proprietary 54 Nasdaq CGEN 54 molecular imaging radiopharmaceuticals 54 Enhanze Technology 54 PNP inhibitor 54 Solazed 54 Nanobody ® 54 Juvantia 54 Dextofisopam 54 Preotact 54 PEP# [003] 54 Commercialization Agreement 54 ZBx 54 oncolytic vaccine 54 Somatuline Depot 54 Alantos 54 SEASONIQUE 54 Solorel 54 molecular chaperone regulation 53 Neurimmune 53 vinorelbine tartrate 53 Mipomersen 53 non nucleoside inhibitor 53 antibody humanization 53 Uracyst R 53 BNC# 53 transmucosal delivery system 53 X Excite 53 Syncria 53 Cardioxyl Pharmaceuticals 53 bardoxolone 53 huC# DM4 53 PDE inhibitor 53 alvespimycin 53 oral ridaforolimus 53 multiple myeloma MM 53 Onco TCS 53 resminostat 53 Intravail R 53 oral taxane 53 gepirone ER 53 Frova ® 53 mTOR inhibition 53 Medigen 53 EHT AGN 53 IV APAP 53 allosteric modulation 53 LymphoStat B TM 53 Santaris 53 research anddevelopment 53 phase Ib clinical 53 SAR# [002] 53 NASDAQ PGNX 53 Amplimexon 53 RTP #i 53 QTinno TM 53 MAGE A3 ASCI 53 OraTest R 53 systemic RNAi 53 volociximab 53 PI3K/Akt pathway inhibitor 53 Zenvia ™ 53 Galderma SA 53 Micromet proprietary BiTE 53 ACOMPLIA R 53 PolyTherics 53 Shire BioChem Inc. 53 2A receptor agonist 53 ancrod 53 Lumacan 53 Prodarsan R 53 Nasdaq PARD biopharmaceutical 53 Biolipox 53 Cellerant 53 BiolineRX 53 relapsed MCL 53 Visian Toric ICL 53 UltiMAb 53 BRIM3 53 OGeS 53 Milestone Payments 53 IGXT IntelGenx today 53 vidofludimus 53 subcutaneous RELISTOR 53 Phase IIIb clinical 53 tramiprosate ALZHEMED TM 53 OraTest 53 UPLYSO 53 Anavex #-# 53 ProMune 53 Curacyte 53 GLPG# 53 LUCASSIN 53 CellGate 53 KB# [002] 53 developing Zerenex ferric 53 IND Investigational New 53 Bella Vita Clinic 53 Exherin TM 53 Invicorp R 53 multicenter Phase II 53 DXL# 53 forodesine 53 Zensana 53 telaprevir VX 53 Trofex 53 midstage clinical 53 Kyowa Kirin 53 successfully commercialize Iluvien 53 Milestone Payment From 53 Solasia 53 GlaxoSmithKline Tykerb 53 Helsinn Healthcare 53 PRECISE trial 53 Q#IR 53 MAXY alpha 53 Proprius Pharmaceuticals 53 Bionutrics 53 Eniluracil 53 Itero 53 Ceplene TM 53 ofatumumab HuMax CD# 52 Onconase 52 entity NCE 52 SILENOR 52 BEMA Buprenorphine 52 ASONEP 52 Marketing Authorisation Application MAA 52 5 FU CVC 52 Vaccinex 52 evaluating satraplatin 52 OMAPRO 52 Troxatyl 52 Thiakis 52 Handok 52 Submits Response 52 preclinical efficacy 52 Phase IIb trials 52 ALN RSV program 52 PDE# inhibitors 52 SAR# [004] 52 Phase 1a clinical 52 EvaMist TM 52 Aryx 52 ELND# 52 Onko Sure ™ 52 Phase 1b clinical trials 52 phase IIb 52 Ventrus 52 LentiVector technology 52 receptor tyrosine kinase inhibitor 52 ProSkelia 52 ALN VSP Phase 52 Strativa 52 pafuramidine maleate 52 bioFILM PA TM 52 EDEMA3 trial 52 BioTie 52 OvaRex ® MAb 52 Zeatin 52 Pliaglis 52 Cellgate Inc. 52 VentiRx 52 Thorough QT 52 GED aPC 52 CHAMPION PCI 52 CDP# 52 ZaBeCor 52 Allovectin 7 R 52 renin inhibition promising 52 IAP inhibitor 52 POTELLIGENT R 52 apricitabine ATC 52 cinacalcet HCl 52 Optiquel ™ 52 MDS AML 52 Eligard ® 52 Nasdaq TRBN 52 Syrrx 52 SCIB1 52 NeuVax 52 intranasal formulation 52 Tyzeka Sebivo 52 Addrenex 52 Evoltra ® 52 LB# [003] 52 oral fludarabine 52 Aztreonam 52 Virulizin R 52 OncoMed 52 Fovea Pharmaceuticals 52 KIACTA ™ 52 3 registrational trial 52 Somatuline R Autogel R 52 Glybera R 52 Apo AIMilano 52 Pierre Fabre Medicament 52 HZT 52 Bioral Amphotericin B 52 CBLC# 52 Abstral ™ 52 MAXY VII 52 Lexiscan ® 52 CIP Fenofibrate 52 Prestara 52 Phase III psoriasis 52 Thorough QT Study 52 HuCAL derived antibody 52 Kirsten Drejer 52 CIMZIA TM 52 Biologic License Application BLA 52 TRACON Pharmaceuticals 52 BEXXAR 52 budesonide foam 52 confirmatory Phase III 52 Astex Therapeutics 52 Phase #/#a 52 Sensipar R 52 ularitide 52 Troxatyl TM 52 mGluR2 positive 52 NanoTab 52 Cytolin 52 apoptosis inducer 52 Affitech 52 TRANSDUR Bupivacaine 52 Hematide ™ peginesatide 52 BN# [004] 52 EGS# 52 midstage trials 52 HuMax EGFr 52 MAA submission 52 Luramist 52 Prednisporin 52 Fodosine 52 HepeX B 52 sumatriptan injection 52 Diamyd ® 52 miconazole Lauriad 52 registrational studies 51 vaginally administered lidocaine 51 SCENESSE ® 51 phase Ib 51 Virulizin 51 Bellicum 51 BrachySil 51 Kyowa Hakko Kirin 51 Sinuwave 51 POSIDUR TM 51 Anturol TM 51 herpetic keratitis 51 clinical pharmacology studies 51 histamine dihydrochloride 51 CytoFab 51 Study #CL# 51 Sigma Tau Pharmaceuticals 51 danoprevir 51 MediWound 51 BLA submission 51 oral ghrelin agonist 51 Cetrotide R 51 BioNumerik 51 Orathecin 51 ALN HTT 51 Phenomix Corporation 51 LEAD Therapeutics 51 Nasdaq MITI 51 Cand5 51 Ophthotech 51 cangrelor 51 orphan designation 51 DCCR 51 PentaStaph 51 rindopepimut 51 ChimeriVax JE 51 MGMT methylation 51 Phase IIa trials 51 MGd 51 orally administered inhibitor 51 DermaVir Patch 51 CNP# 51 BioSeek 51 StemEx R 51 PEG SN# 51 eprodisate KIACTA TM 51 goserelin 51 alkylating agent 51 Alnara Pharmaceuticals 51 Paris IPN 51 TRO# 51 Wellstat 51 PRESEPT study 51 Miikana 51 non nucleoside HCV 51 InterfeRx 51 DP VPA 51 Phenomix 51 Fibrillex TM 51 NP2 Enkephalin 51 Unit Dose Budesonide 51 Calixa 51 Selective Electrochemical Tumor Ablation 51 Manja Bouman CEO 51 enzyme rHuPH# 51 Receives Milestone Payment 51 hematological indications 51 Zeneus Holdings 51 balsalazide tablet 51 EOquin 51 Traficet EN 51 PFO migraine 51 FlutiformTM 51 relapsed MM 51 CCR5 antagonist 51 talactoferrin 51 Roche SWX ROG 51 PMA submission 51 inhaled prostacyclin 51 inhaled antibiotic 51 bicifadine 51 MEND CABG II 51 Plicera 51 Annamycin 51 fostamatinib 51 sigma tau Group 51 obatoclax 51 Alzhemed TM 51 Novexel 51 VaxImmune 51 RenaZorb TM 51 Dacogen injection 51 Vantas 51 ViroChem Pharma Inc. 51 Asentar TM 51 NASDAQ OSIR 51 GRNVAC1 51 Apexigen 51 Abstral ® 51 Asentar 51 EyeTel 51 paclitaxel poliglumex 51 Inc. NASDAQ NOVC 51 CLIRS trial 51 recombinant biopharmaceutical 51 Capesaris 51 PD2i CA 51 pixantrone NDA 51 Conforma 51 posaconazole 51 mSEPT9 biomarker 51 stated Michelle Berrey 51 HuLuc# 51 rhThrombin 51 PRIMO CABG 51 phase IIa 51 Lung Rx 51 registrational 50 XERECEPT R 50 PharmaSwiss SA 50 CRACM 50 brentuximab vedotin SGN 50 ZEGERID Capsules 50 Milestone Payment 50 Intas 50 Mesafem 50 MONOVISC 50 cannabinor 50 Nasdaq PGNX today 50 Chroma Therapeutics 50 PS# DARA 50 Nascobal 50 NeuroMedix 50 IIb clinical trial 50 Protez 50 Saforis 50 AnGes MG Inc. 50 Durect 50 dacetuzumab 50 Memryte 50 dexanabinol 50 ANAVEX #-# [001] 50 Posidur 50 DAC HYP 50 Gastrotech 50 Phase III ADT 50 recurrent herpes labialis 50 Miikana Therapeutics 50 Specifar 50 IMiDs R 50 Oncotype DX colon cancer 50 CFFT 50 UVIDEM 50 Canadian drugmaker Aeterna 50 indibulin 50 GlycoPEG GCSF 50 FROVA 50 recombinant PSMA vaccine 50 GPR# agonist 50 EXPLORE Xa 50 Triapine R 50 ANCHOR trial 50 Dr. Fahar Merchant 50 NeoDisc 50 PANVAC VF 50 Receive Milestone Payment 50 ENZON 50 Proquin XR 50 Neogenix 50 Acapodene R 50 Afinion 50 CG# [003] 50 Raf kinase inhibitor 50 alemtuzumab MS 50 Harry Palmin President 50 OraQuick ® 50 oral opioid modulator 50 Maxy G# 50 Cloretazine 50 MIVT 50 nucleoside polymerase inhibitor 50 homocysteine assay 50 Ception 50 CLIA certification 50 DepoMed 50 MVax 50 Biological License Application 50 EDEMA3 50 AIMM trial 50 Proprius 50 BiDil XR 50 Astex 50 oral rivaroxaban 50 dermatology biopharmaceutical company 50 Zor Pharmaceuticals 50 StemEx 50 delivery polymer matrix 50 omacetaxine mepesuccinate 50 CONBRIZA 50 NV Organon 50 lintuzumab SGN 50 SEPET TM 50 targeted molecular radiotherapeutics 50 octreotide implant 50 generic enoxaparin 50 generation calcineurin inhibitor 50 Zemplar Capsules 50 HCD# [002] 50 Pennsaid Plus 50 TransMID 50 NASDAQ SGEN 50 COLAZAL R 50 EVIZON ™ 50 Phase 2a clinical trials 50 Psivida 50 Augment Injectable 50 Immunotherapeutic 50 Revance 50 dose escalation clinical 50 Norgine BV 50 TOCOSOL 50 Agensys subsidiary 50 ICON7 50 HYLENEX recombinant 50 Emselex 50 Nanobodies 50 Hematide ™ 50 AdhTAP 50 Excellagen 50 Epitan 50 dose escalation 50 Ostabolin C TM 50 Pafuramidine 50 Phase #b/#a trial 50 systemically administered 50 PTH1 50 oral nucleoside analogue 50 ABX EGF 50 SPRIX ® 50 R#/MEM # 50 Zentaris 50 Urokinase 50 Lycera 50 Avantome 50 KaloBios Pharmaceuticals 50 CollaRx GENTAMICIN SURGICAL IMPLANT 50 Phase IIA 50 Scil Technology 50 NOXXON 50 Phase IIB 50 Verigene System 50 MethyPatch 50 AsepticSure 50 Phase 1b 50 Intellikine 50 indiplon capsules 50 Vicor anticipates 50 commercialize elagolix 50 Synerx 50 MIST II 50 Nasdaq OPTR 50 Cetirizine Hydrochloride Syrup 50 E1 INT TM 50 Caliper microfluidics 50 NEBIDO 50 dermaPACE ™ 50 Amplimmune 50 Million Milestone Payment 50 Ono Pharmaceutical 49 Announces Poster Presentations 49 JAK3 49 BCIRG 49 oral talactoferrin 49 treatment naive genotype 49 Bema Fentanyl 49 Prosaptide 49 Phase 2a trial 49 Acetylon 49 aurora kinase 49 Kaketsuken 49 Plexxikon 49 Trubion Pharmaceuticals 49 Provecta 49 lesinurad 49 subcutaneous methylnaltrexone 49 OncoGenex Technologies 49 Tego Biosciences 49 PentaLyte 49 phase IIb study 49 RSD# oral 49 JUVISTA 49 phase IIb III 49 celgosivir 49 Moli# 49 Inc. Nasdaq ATHX 49 Napo Pharmaceuticals 49 drug conjugate ADC 49 isavuconazole 49 Tarceva TM 49 rPA anthrax vaccine 49 naronapride 49 sterile lidocaine patch 49 maturation inhibitor 49 Oncaspar 49 Distributorship Agreement 49 ITAX 49 ThyroTest R 49 CLIRS 49 OMJPI 49 Behcet uveitis 49 Isis Pharma 49 tolevamer 49 Nascobal ® 49 Catalyst Biosciences 49 dermatology biopharmaceutical 49 OMNARIS HFA 49 Gammagard Liquid 49 generic Valtrex 49 Indaflex 49 IMiDs ® compound 49 DEEP AF 49 MGN# 49 elvucitabine 49 cMET inhibitor 49 sitaxsentan 49 LEP ETU 49 Phase IIa clinical trials 49 Medidur FA 49 oilbody 49 ZARS 49 Rottapharm Madaus 49 Raven Biotechnologies 49 Avian Transgenic Technology 49 Nasdaq ALNY 49 molecular imaging pharmaceuticals 49 Alnara 49 Kenta Biotech 49 vinorelbine emulsion 49 initiate Phase IIb 49 Juvaris 49 Astex Therapeutics Limited 49 buccal delivery 49 PCA3 prostate cancer 49 OX2 engine 49 Tolerx 49 Solzira 49 unit AbD Serotec 49 Valeant Pharma 49 TASKi3 49 confirmatory Phase 3 49 Zymafos 49 Posiphen 49 rALLy trial 49 Testosterone MDTS R 49 lintuzumab 49 Viamet 49 Phase III randomized controlled 49 pain palliation 49 Nasdaq CRXX 49 SPRYCEL ® 49 Azmacort 49 LibiGel NDA 49 HDACi 49 Jingxin Pharma 49 Transgene therapeutic 49 APEX PD 49 Evamist TM 49 phage display technology 49 FDA approvable letter 49 CALGB # [002] 49 Frova R 49 FluINsure 49 BioInvent 49 markets Testim ® 49 proprietary transdermal patch 49 PhG alpha 1 49 aEURoeThis 49 Canvaxin 49 HCV polymerase 49 Inc. NASDAQ ZLCS 49 Laquinimod 49 dosing cohort 49 Phase IIIB IV 49 Cutanea Life Sciences 49 drug tesmilifene 49 candidate FavId 49 Orapred ODT 49 DermaSphere R Technology 49 commercialize becocalcidiol patented 49 SNS# T 49 almorexant 49 vernakalant hydrochloride 49 GLP1 agonist 49 nab paclitaxel 49 dose cohort 49 Paladin Labs 49 Perforomist TM formoterol fumarate 49 evaluating Actimmune 49 OncoVex 49 commercialization milestones 49 OLEPTRO TM 49 Triglide 49 TransVax tm 49 4SC commented 49 cortical stimulation 49 Captisol ® 49 ColorectAlert TM 49 Impavido R 49 ACCLAIM II 49 desvenlafaxine succinate 49 Onyx Pharma 48 beta secretase inhibitor 48 XERECEPT 48 HQK 48 highly selective adenosine 48 CytoFab ™ 48 Reloxin R 48 PD2i Analyzer 48 IND enabling 48 oral NKTR 48 sublicensee 48 Nycomed GmbH 48 ESBATech AG 48 Phase 1a 48 PRESEPT 48 inecalcitol 48 initiate multicenter 48 Zymo 48 subcutaneous formulation 48 Phase Ib 48 Albugon 48 PINK MBLTY 48 Thorough QT TQT 48 Agennix Incorporated 48 Celera Diagnostics joint venture 48 Partnering Guide 48 Primera Bioscience 48 Mitsubishi Tanabe 48 Opsona Therapeutics 48 proprietary electroporation 48 Genome Diagnostics 48 blinded randomized 48 PharmaBio Development 48 fosbretabulin 48 elacytarabine 48 Targretin capsules 48 Bellicum Pharmaceuticals Inc. 48 oral methylnaltrexone 48 Aloprim 48 EmbraceAC 48 PI3 K 48 Orphan Drug designation 48 Androxal TM 48 TLK# 48 CorNova 48 RAPTIVA R 48 AZX# 48 OMS#HP 48 BioVex 48 Albany Molecular AMRI 48 OXi# 48 BioDelivery Sciences 48 genomic biomarker 48 SansRosa 48 Pierre Fabre Laboratories 48 Dose escalation 48 MPL adjuvant 48 CYT# potent vascular disrupting 48 Cloretazine R 48 doxorubicin docetaxel 48 Salmedix 48 Annexin V 48 Gestiva TM 48 ImmuneY2 48 Starpharma dendrimer 48 Zemiva 48 provides adenoviral reagents 48 SYMMETRY trial 48 Xcellerated T Cells 48 Miracor 48 Corlux 48 TheraCIM h R3 48 commercialize AzaSite 48 edifoligide 48 Somatuline Autogel 48 Cabilly patent 48 BioSante Pharmaceuticals Announces 48 isatoribine 48 AclarusDx ™ 48 Cytori NASDAQ CYTX 48 Inc NGSX 48 safflower produced 48 Cinquil 48 Dainippon Sumitomo 48 frovatriptan 48 LFRP 48 Galephar 48 Pharma Medica 48 PDL# 48 ASCT 48 budesonide MMX Phase III 48 SynthRx 48 Bioral 48 LUMINATE 48 statistically significant efficacy 48 solanezumab 48 miRNA therapeutics 48 Unifill TM syringe 48 AkaRx 48 ARISE Phase III 48 intranasal ketamine 48 Phase III TRIST 48 EVIZON TM 48 Tech DVAX 48 Symadex 48 clevudine 48 dirucotide 48 Syntonix Pharmaceuticals 48 Flutiform 48 AnorMED expectation 48 Pharmacokinetic studies 48 riociguat 48 ENRICH trial 48 Janssen AI 48 Sumavel DosePro 48 Phase 2b kidney transplant 48 AMPAKINE CX# 48 Ambrx 48 hoFH 48 OVATURE 48 BioCancell 48 Megace R ES 48 huN# DM1 48 Alder Biopharmaceuticals Inc. 48 Amikacin Inhale 48 ForSight Newco II 48 SuperAntibody 48 FIRMAGON R 48 Preclinical studies suggest 48 L BLP# 48 Kahalalide F 48 Licensing Agreements 48 JXTC 48 Aganocide TM 48 confirmatory pivotal 48 Phase III Clinical Trials 48 MAb therapy 48 RxKinetix 48 DACH platinum 48 Study NX# 48 polymer platinate 48 Thalomid ® 48 Ethypharm SA 48 PREGNANT Study 48 Sonatherm 48 Dealmaking Profile 48 IMC A# 48 piperacillin tazobactam 48 Isis antisense 48 confirmatory clinical 48 macitentan 47 rhIGF-I/rhIGFBP-3 47 NASDAQ MOGN 47 PROMACTA ® 47 CoGenesys 47 collaborator Genentech 47 NDA resubmission 47 progressive metastatic prostate 47 lorcaserin Phase 47 Dr. Rentrop 47 GALNS 47 Hervé Hoppenot President 47 partner Lux Biosciences 47 Fanapt ™ 47 faropenem medoxomil 47 Gruenenthal 47 HCV antiviral 47 Jaiva Technologies 47 Exclusive License 47 Cerexa Inc. 47 ImmunoGen TAP technology 47 CCR5 inhibitor